Publications by Center Staff

Results of a High Resolution Genome Screen of 437 Alzheimer’s Disease Families
2003

Blacker D, Bertram L, Saunders AJ, Moscarillo TJ, Albert MS, Wiener W, Perry RT, Collins JS, Harrell LE, Go RCP, Mahoney A, Beaty T, Fallin MD, Avramopoulos D, Chase GA, Folstein MF, McInnis MG, Bassett SS, Doheny KJ, Pugh EW and Tanzi RE (2003). Results of a high resolution genome screen of 437 alzheimer’s disease families. Hum Molec Genet; 12: 23-32.

Selective Impairment of Frontal-Executive Cognitive Function in African-Americans with Cardiovascular Risk Factors
2003

Pugh KG, Kiely DK, Milberg WP and Lipsitz LA (2003). Selective impairment of frontal-executive cognitive function in african americans with cardiovascular risk factors. J Am Geriatr Soc; 51: 1439-1444.

Selective Reduction of Soluble Tau Proteins in Sporadic and Familial Frontotemporal Dementias: an International Follow-Up Study
2003

Zhukareva V, Sundarraj S, Mann D, Sjogren M, Blenow K, Clark CM, McKeel DW, Goate A, Lippa CF, Vonsattel JP, Growdon JH, Trojanowski JQ, Lee VM (2003).  Selective reduction of soluble tau proteins in sporadic and familial frontotemporal dementias:  an international follow-up study.  Acta Neuropathologica; 105:469-476.

Statins in Prevention and Treatment of Alzheimer’s Disease
2003

Drachman DA (2003). Statins in prevention and treatment of alzheimer’s disease. Current Clinical Neurology, Alzheimer's Disease:  A Physician's Guide to Practical Management.  Richter RW and Richter BZ (Eds.). Totowa, NJ, Humana Press Inc:  253-257.

Working Memory in Mild AD and Early Parkinson’s Disease
2003

Kensinger EA, Shearer DK, Locascio JJ, Growdon JH, Corkin S. (2003). Working memory in mild ad and early parkinson’s disease.  Neuropsychology; 17: 230-239.

A Lipophilic Thioflavin-T Derivative for Positron Emission Tomography (PET) Imaging of Amyloid in Brain
2002

Mathis CA, Bacskai BJ, Kaidasz ST, McLellan ME, Frosch MP, Hyman BT, Holt DP, Wang Y, Huang GF, Debnath ML and Klunk WE (2002). A lipophilic thioflavin-t derivative for positron emission tomography (pet) imaging of amyloid in brain. Bioorg Med Chem Lett; 12: 295-298.

A Mathematical Model of the Impact of Novel treatments on the Aß Burden in the Alzheimer’s Brain, CSF and Plasma
2002

Craft DL, Wein LM and Selkoe DJ (2002). A mathematical model of the impact of novel treatments on the aß burden in the alzheimer’s brain, csf and plasma. Bulletin of Mathematical Biology; 64: 1011-1031.

Aging and Dementia: Principles, Evaluation and Diagnosis
2002

Seshadri S and Drachman DA (2002). Aging and dementia:  principles, evaluation and diagnosis. Diseases of the Nervous System (3rd Ed.). A Asbury, G McKhann, W McDonald, P Goadsby and J McArthur (Eds.). Cambridge, UK, Cambridge University Press:  237-251.

Alzheimer’s Disease
2002

Kelleher RJ and Growdon JH (2002). Alzheimer’s disease. Diseases of the Nervous System:  Clinical Neuroscience and Therapeutic Principles (3rd ed.). AK Asbury, GH McKhann, WI McDonald, PJ Goadsby and JC McArthur (Eds.). Cambridge, UK, Cambridge University Press:  252-266.

Alzheimer’s Disease is a Synaptic Failure
2002

Selkoe DJ (2002). Alzheimer’s disease is a synaptic failure. Science; 298:  789-791.